| The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases J Alijotas-Reig, E Esteve-Valverde, R Ferrer-Oliveras, L Sáez-Comet, ... Autoimmunity reviews 18 (4), 406-414, 2019 | 106 | 2019 |
| Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions J Trapé, R Molina, F Sant Tumor biology 25 (5-6), 276-281, 2004 | 105 | 2004 |
| Increased plasma concentrations of tumour markers in the absence of neoplasia J Trapé, X Filella, M Alsina-Donadeu, L Juan-Pereira, A Bosch-Ferrer, ... Clinical Chemistry and Laboratory Medicine 49 (10), 1605-1620, 2011 | 103 | 2011 |
| Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients J Trape, C Morales, R Molina, X Filella, JM Marcos, R Salinas, ... Scandinavian journal of clinical and laboratory investigation 66 (3), 261-267, 2006 | 78 | 2006 |
| Tumor markers as prognostic factors in treated non-small cell lung cancer. J Trapé, J Buxo, J Pérez de Olaguer, C Vidal Anticancer research 23 (5b), 4277-4281, 2003 | 73 | 2003 |
| Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry J Alijotas-Reig, E Esteve-Valverde, R Ferrer-Oliveras, L Sáez-Comet, ... Rheumatology 59 (6), 1306-1314, 2020 | 69 | 2020 |
| Serum concentrations of vascular endothelial growth factor in advanced non-small cell lung cancer J Trapé, J Buxó, JP de Olaguer Clinical Chemistry 49 (3), 523-525, 2003 | 44 | 2003 |
| Reference change value for α-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease J Trape, JM Botargues, F Porta, C Ricos, JM Badal, R Salinas, M Sala, ... Clinical chemistry 49 (7), 1209-1211, 2003 | 41 | 2003 |
| Biological variation of tumor markers and its application in the detection of disease progression in patients with non-small cell lung cancer J Trape, J Pérez de Olaguer, J Buxo, L Lopez Clinical chemistry 51 (1), 219-222, 2005 | 30 | 2005 |
| Reference change value for HbA1c in patients with type 2 diabetes mellitus J Trapé, M Aliart, M Brunet, E Dern, E Abadal, JM Queraltó Walter de Gruyter 38 (12), 1283-1287, 2000 | 26 | 2000 |
| Evaluation of two strategies for the interpretation of tumour markers in pleural effusions J Trapé, F Sant, J Franquesa, J Montesinos, A Arnau, M Sala, ... Respiratory Research 18, 1-8, 2017 | 24 | 2017 |
| Diagnostic accuracy of tumour markers in serous effusions: a validation study J Trapé, R Molina, F Sant, J Montesinos, A Arnau, J Franquesa, R Blavia, ... Tumor Biology 33, 1661-1668, 2012 | 23 | 2012 |
| Previous SARS-CoV-2 infection increases B. 1.1. 7 cross-neutralization by vaccinated individuals B Trinité, E Pradenas, S Marfil, C Rovirosa, V Urrea, F Tarrés-Freixas, ... Viruses 13 (6), 1135, 2021 | 22 | 2021 |
| A prognostic score based on clinical factors and biomarkers for advanced non-small cell lung cancer J Trapé, J Montesinos, S Catot, J Buxó, J Franquesa, M Sala, ... The International journal of biological markers 27 (3), 257-262, 2012 | 21 | 2012 |
| Cardiac performance after an endurance open water swimming race V Martinez, MS la Garza, G Grazioli, BH Bijnens, J Trapé, G Garcia, ... European journal of applied physiology 119, 961-970, 2019 | 18 | 2019 |
| Clinical utility of determining tumor markers in patients with signs and symptoms of cancer J Trapé, M Sala, F Franquesa, JM Ordeig, JM Soler-Bel, E Bustamante, ... Clinical Chemistry and Laboratory Medicine (CCLM) 53 (3), 485-491, 2015 | 16 | 2015 |
| Diagnostic accuracy of tumor markers CYFRA21-1 and CA125 in the differential diagnosis of ascites J Trape, G Gurt, J Franquesa, J Montesinos, A Arnau, M Sala, F Sant, ... Anticancer research 35 (10), 5655-5660, 2015 | 14 | 2015 |
| Randomized clinical trial to evaluate the effect of a supervised exercise training program on readmissions in patients with myocardial ischemia: a study protocol N Santaularia, J Caminal, A Arnau, M Perramon, J Montesinos, J Trapé, ... BMC Cardiovascular Disorders 13, 1-8, 2013 | 12 | 2013 |
| Nt‐proBNP in haemodialysis patients: A preliminary study J Trapé, A Pérez, I Naval, J Escudero, I Comerma, A Sans, J Franquesa, ... Scandinavian Journal of Clinical and Laboratory Investigation 68 (5), 415-420, 2008 | 12 | 2008 |
| Synthetic applications of 2-aryl-4-piperidones. V1.: Synthesis of the fundamental tetracyclic skeleton of ervitsine and its 20-deethylidene-6, 16-dihydro analogue M Rubiralta, MP Marco, J Bolós, J Trapé Tetrahedron 47 (29), 5585-5602, 1991 | 11 | 1991 |
